Machine learning in prostate MRI for prostate cancer: current status and future opportunities

Advances in our understanding of the role of magnetic resonance imaging (MRI) for the detection of prostate cancer have enabled its integration into clinical routines in the past two decades. The Prostate Imaging Reporting and Data System (PI-RADS) is an established imaging-based scoring system that...

Full description

Saved in:
Bibliographic Details
Main Authors: Li, Huanye, Lee, Chau Hung, Chia, David, Lin, Zhiping, Huang, Weimin, Tan, Cher Heng
Other Authors: School of Electrical and Electronic Engineering
Format: Article
Language:English
Published: 2022
Subjects:
Online Access:https://hdl.handle.net/10356/160624
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-160624
record_format dspace
spelling sg-ntu-dr.10356-1606242022-07-28T08:19:40Z Machine learning in prostate MRI for prostate cancer: current status and future opportunities Li, Huanye Lee, Chau Hung Chia, David Lin, Zhiping Huang, Weimin Tan, Cher Heng School of Electrical and Electronic Engineering Lee Kong Chian School of Medicine (LKCMedicine) Engineering::Electrical and electronic engineering Prostate Magnetic Resonance Imaging Cancer Advances in our understanding of the role of magnetic resonance imaging (MRI) for the detection of prostate cancer have enabled its integration into clinical routines in the past two decades. The Prostate Imaging Reporting and Data System (PI-RADS) is an established imaging-based scoring system that scores the probability of clinically significant prostate cancer on MRI to guide management. Image fusion technology allows one to combine the superior soft tissue contrast resolution of MRI, with real-time anatomical depiction using ultrasound or computed tomography. This allows the accurate mapping of prostate cancer for targeted biopsy and treatment. Machine learning provides vast opportunities for automated organ and lesion depiction that could increase the reproducibility of PI-RADS categorisation, and improve co-registration across imaging modalities to enhance diagnostic and treatment methods that can then be individualised based on clinical risk of malignancy. In this article, we provide a comprehensive and contemporary review of advancements, and share insights into new opportunities in this field. Published version 2022-07-28T08:19:39Z 2022-07-28T08:19:39Z 2022 Journal Article Li, H., Lee, C. H., Chia, D., Lin, Z., Huang, W. & Tan, C. H. (2022). Machine learning in prostate MRI for prostate cancer: current status and future opportunities. Diagnostics, 12(2), 289-. https://dx.doi.org/10.3390/diagnostics12020289 2075-4418 https://hdl.handle.net/10356/160624 10.3390/diagnostics12020289 35204380 2-s2.0-85124106159 2 12 289 en Diagnostics © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/). application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Engineering::Electrical and electronic engineering
Prostate Magnetic Resonance Imaging
Cancer
spellingShingle Engineering::Electrical and electronic engineering
Prostate Magnetic Resonance Imaging
Cancer
Li, Huanye
Lee, Chau Hung
Chia, David
Lin, Zhiping
Huang, Weimin
Tan, Cher Heng
Machine learning in prostate MRI for prostate cancer: current status and future opportunities
description Advances in our understanding of the role of magnetic resonance imaging (MRI) for the detection of prostate cancer have enabled its integration into clinical routines in the past two decades. The Prostate Imaging Reporting and Data System (PI-RADS) is an established imaging-based scoring system that scores the probability of clinically significant prostate cancer on MRI to guide management. Image fusion technology allows one to combine the superior soft tissue contrast resolution of MRI, with real-time anatomical depiction using ultrasound or computed tomography. This allows the accurate mapping of prostate cancer for targeted biopsy and treatment. Machine learning provides vast opportunities for automated organ and lesion depiction that could increase the reproducibility of PI-RADS categorisation, and improve co-registration across imaging modalities to enhance diagnostic and treatment methods that can then be individualised based on clinical risk of malignancy. In this article, we provide a comprehensive and contemporary review of advancements, and share insights into new opportunities in this field.
author2 School of Electrical and Electronic Engineering
author_facet School of Electrical and Electronic Engineering
Li, Huanye
Lee, Chau Hung
Chia, David
Lin, Zhiping
Huang, Weimin
Tan, Cher Heng
format Article
author Li, Huanye
Lee, Chau Hung
Chia, David
Lin, Zhiping
Huang, Weimin
Tan, Cher Heng
author_sort Li, Huanye
title Machine learning in prostate MRI for prostate cancer: current status and future opportunities
title_short Machine learning in prostate MRI for prostate cancer: current status and future opportunities
title_full Machine learning in prostate MRI for prostate cancer: current status and future opportunities
title_fullStr Machine learning in prostate MRI for prostate cancer: current status and future opportunities
title_full_unstemmed Machine learning in prostate MRI for prostate cancer: current status and future opportunities
title_sort machine learning in prostate mri for prostate cancer: current status and future opportunities
publishDate 2022
url https://hdl.handle.net/10356/160624
_version_ 1739837427014434816